ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
0.00%
Bitcoin
62,921.79
0.05%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Revolution Medicines Inc (RVMD)

  7. Revolution Medicines Inc (RVMD) Noticias

RVMD Revolution Medicines Inc

40.90
1.71 (4.36%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Revolution Medicines Inc RVMD NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
1.71 4.36% 40.90 18:58:55
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
40.00 39.10 40.21 40.20 39.19
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
01/5/202415:05GLOBERevolution Medicines to Report Financial Results for First..
09/4/202414:34GLOBERevolution Medicines Announces Publication on the Discovery..
08/4/202410:36GLOBERevolution Medicines Announces Publications on the Discovery..
04/4/202415:05GLOBERevolution Medicines to Participate in Upcoming Investor..
28/3/202415:05GLOBERevolution Medicines to Deliver Multiple Presentations at..
05/3/202415:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202415:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202415:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202416:23EDGAR2Form S-3ASR - Automatic shelf registration statement of..
26/2/202416:04EDGAR2Form S-8 - Securities to be offered to employees in employee..
26/2/202415:05GLOBERevolution Medicines Reports Fourth Quarter and Full Year..
26/2/202415:04EDGAR2Form 8-K - Current report
20/2/202415:05GLOBERevolution Medicines to Report Financial Results for Fourth..
09/2/202416:22EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/2/202415:05GLOBERevolution Medicines to Participate in Upcoming Investor..
24/1/202415:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202415:18EDGAR2Form 144 - Report of proposed sale of securities
09/1/202413:15EDGAR2Form 8-K - Current report
04/1/202406:00GLOBERevolution Medicines to Present at 42nd Annual J.P...
20/12/202316:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202316:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202317:22EDGAR2Form 144 - Report of proposed sale of securities
14/12/202316:48EDGAR2Form 144 - Report of proposed sale of securities
20/11/202317:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202315:14EDGAR2Form 144 - Report of proposed sale of securities
16/11/202313:58EDGAR2Form CERT - Certification by an exchange approving..
15/11/202315:04EDGAR2Form 8-A12B - Registration of securities [Section 12(b)]
14/11/202319:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202319:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202319:13EDGAR2Form 3 - Initial statement of beneficial ownership of..
09/11/202308:20EDGAR2Form 8-K - Current report
09/11/202308:10GLOBERevolution Medicines Completes Acquisition of EQRx
08/11/202310:30GLOBERevolution Medicines and EQRx Stockholders Approve EQRx..
06/11/202315:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202315:05GLOBERevolution Medicines Reports Third Quarter 2023 Financial..
06/11/202315:05EDGAR2Form 8-K - Current report
01/11/202306:15EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
01/11/202306:11EDGAR2Form 425 - Prospectuses and communications, business..
01/11/202306:08EDGAR2Form 8-K - Current report
01/11/202306:00GLOBELeading Independent Proxy Advisory Firms ISS and Glass Lewis..
31/10/202315:15GLOBERevolution Medicines to Report Financial Results for Third..
23/10/202317:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/10/202305:13EDGAR2Form 425 - Prospectuses and communications, business..
23/10/202305:11EDGAR2Form 8-K - Current report
22/10/202301:30GLOBERevolution Medicines Presents Promising Clinical Activity..
13/10/202310:54EDGAR2Form 8-K - Current report
13/10/202310:50GLOBERevolution Medicines Presents Encouraging Clinical Data for..
04/10/202315:05GLOBERevolution Medicines to Present New Clinical Data at Major..
02/10/202315:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202315:19EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..

Su Consulta Reciente

NASDAQ
RVMD
Revolution Medicines
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados